{
  "created_at": "Mon Jun 21 20:11:58 +0000 2021",
  "id_str": "1406941235823190018",
  "full_text": "Covid-19 vaccine maker Moderna is rapidly expanding to increase output at its main manufacturing plant by 50% by early 2022. The extra doses could supply countries outside the U.S. and make boosters.  https://t.co/bteUYyia38",
  "display_text_range": [
    0,
    224
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/bteUYyia38",
        "expanded_url": "https://on.wsj.com/3cXGKQ4",
        "display_url": "on.wsj.com/3cXGKQ4",
        "indices": [
          201,
          224
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 36,
  "favorite_count": 112,
  "possibly_sensitive": false,
  "original_created_at": "Mon Jun 21 11:45:04 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "Covid-19ワクチンメーカーのModerna社は、2022年初頭までに主要製造工場の生産量を50％増加させるため、急速に拡大しています。増産分は米国以外の国に供給し、ブースターを作ることができる。https://t.co/bteUYyia38"
    },
    {
      "locale": "zh",
      "full_text": "Covid-19疫苗制造商Moderna正在迅速扩张，以便在2022年初将其主要制造厂的产量提高50%。额外的剂量可以供应美国以外的国家，并制作助推器。https://t.co/bteUYyia38"
    },
    {
      "locale": "zh-Hant",
      "full_text": "Covid-19疫苗製造商Moderna正在迅速擴張，以便在2022年初將其主要製造廠的產量提高50%。額外的劑量可以供應美國以外的國家，並製作助推器。https://t.co/bteUYyia38"
    }
  ]
}